Composition
- Active ingredients
- DENILEUKIN DIFTITOX-CXDL 300MCG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761312.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lymphir
- Active substance
- denileukin diftitox-cxdl
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Citius Pharms
- Status
- Prescription
- FDA approval
- 7 Aug 2024
- Application
- BLA761312-001